Cardioneuroablation for severe fainting with heart pauses
Part of Brain & nervous system clinical trials.
This trial tests a procedure called cardioneuroablation to treat severe fainting (reflex syncope) that hasn't been helped by other treatments. The goal is to see if it reduces fainting without causing dangerous heart rhythm problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe, repeated fainting spells caused by reflex syncope, and a heart monitor showed your heart paused for more than 3 seconds.
- You have tried non-medication treatments (like lifestyle changes) that didn't help.
- You had a positive atropine test, which means your heart sped up normally after a medication injection.
- You are willing to give written consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure called cardioneuroablation, which uses targeted heat (radiofrequency) to calm overactive nerves that cause your heart to beat too slowly and make you faint. The goal is to stop severe fainting spells in people with reflex syncope who haven't gotten better with other treatments.
This registry tracks people who receive a heart procedure called cardioneuroablation to stop severe fainting spells. The procedure targets nerve signals that cause the heart to pause, and researchers want to learn how well it works in real-world patients.
This trial compares two procedures to treat very slow heart rates without needing a pacemaker. One uses freezing (cryoablation) and the other uses radiofrequency energy to target nerves that control heart rate.
This study compares a procedure called cardioneuroablation with staying on permanent pacing in people who have symptoms from a slow heart rate. It aims to see which approach works better and is safer for reducing symptoms related to sinus node or heart conduction problems.
This trial tests a device called an implantable loop recorder (a small monitor placed under the skin) along with a procedure called cardioneuroablation, which targets nerves that may cause fainting. It is designed for people with frequent, severe fainting due to reflex syncope.
This trial studies a procedure that targets a specific heart nerve area on the right side to reduce neurally mediated fainting (syncope). You may be a candidate if your fainting is linked to heart rhythm/nerve reflexes and you meet several heart-function and heart-rhythm test criteria.
Hear when a new Syncope, Vasovagal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.